Literature DB >> 15093829

Tumor necrosis factor family ligand-receptor binding.

Gongyi Zhang1.   

Abstract

Ligands and receptors of the tumor necrosis factor (TNF) superfamily have pivotal roles in the development and function of the immune system. The growing pool of data on TNF from structural and biochemical studies suggests that the higher order clustering of TNF family ligands could play an essential role in signal transduction initiation for this superfamily. The identification of new structural modules of TNF family receptors, as well as interaction modes between ligands and receptors, greatly expands our knowledge of how TNF family ligands and receptors determine specificity among diverse family members and between two closely related family members.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15093829     DOI: 10.1016/j.sbi.2004.03.003

Source DB:  PubMed          Journal:  Curr Opin Struct Biol        ISSN: 0959-440X            Impact factor:   6.809


  23 in total

1.  The LIGHT and DARC sides of herpesvirus entry mediator.

Authors:  Tania H Watts; Jennifer L Gommerman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-13       Impact factor: 11.205

2.  Harnessing poxviral know-how for anti-cytokine therapies.

Authors:  Andrew G Bowie
Journal:  J Biol Chem       Date:  2019-03-29       Impact factor: 5.157

3.  Probing the Arabidopsis flagellin receptor: FLS2-FLS2 association and the contributions of specific domains to signaling function.

Authors:  Wenxian Sun; Yangrong Cao; Kristin Jansen Labby; Pascal Bittel; Thomas Boller; Andrew F Bent
Journal:  Plant Cell       Date:  2012-03-02       Impact factor: 11.277

4.  Targeted Cancer Therapy with Tumor Necrosis Factor-Alpha.

Authors:  Weibo Cai; Zachary J Kerner; Hao Hong; Jiangtao Sun
Journal:  Biochem Insights       Date:  2008-07-22

5.  Structure-based development of a receptor activator of nuclear factor-kappaB ligand (RANKL) inhibitor peptide and molecular basis for osteopetrosis.

Authors:  Hai Minh Ta; Giang Thi Tuyet Nguyen; Hye Mi Jin; Jongkeun Choi; Hyejin Park; Nacksung Kim; Hye-Yeon Hwang; Kyeong Kyu Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-08       Impact factor: 11.205

6.  B-lymphocyte-induced maturation protein1 up-regulates the expression of B-cell maturation antigen in mouse plasma cells.

Authors:  Shaoli Deng; Tao Yuan; Xiaoxing Cheng; Rui Jian; Jing Jiang
Journal:  Mol Biol Rep       Date:  2010-03-26       Impact factor: 2.316

7.  The murine equivalent of the A181E TACI mutation associated with common variable immunodeficiency severely impairs B-cell function.

Authors:  John J Lee; Ingrid Rauter; Lilit Garibyan; Esra Ozcan; Tatyana Sannikova; Stacey R Dillon; Anthony C Cruz; Richard M Siegel; Richard Bram; Haifa Jabara; Raif S Geha
Journal:  Blood       Date:  2009-07-15       Impact factor: 22.113

Review 8.  Anti-cancer therapy with TNFα and IFNγ: A comprehensive review.

Authors:  Jing Shen; Zhangang Xiao; Qijie Zhao; Mingxing Li; Xu Wu; Lin Zhang; Wei Hu; Chi H Cho
Journal:  Cell Prolif       Date:  2018-02-26       Impact factor: 6.831

9.  Human glucocorticoid-induced TNF receptor ligand regulates its signaling activity through multiple oligomerization states.

Authors:  Zhaocai Zhou; Xiaomin Song; Alan Berezov; Geng Zhang; Yanjing Li; Hongtao Zhang; Ramachandran Murali; Bin Li; Mark I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-31       Impact factor: 11.205

10.  Biologics: target-specific treatment of systemic and cutaneous autoimmune diseases.

Authors:  Siba P Raychaudhuri; Smriti K Raychaudhuri
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.